Scilex to invest $150m in Datavault AI.

Scilex Holding Company, a pharmaceutical company, agreed to invest $150m in Datavault AI, a technology company specializing in AI-driven data. "Datavault's cutting-edge technologies align perfectly with the biotech sector's need for advanced data analytics, AI-driven insights, and supercomputing power. This investment reflects our belief in Datavault’s ability to transform markets where trust and precision are critical. Biotech is a market we know well, and we will help guide Datavault to maximum revenue generation in our sector while Datavault expand," Henry Ji, Scilex CEO, President and Chairman of the Board.